Many signaling, cytoskeletal, and transport proteins have to be localized to the plasma membrane (PM) in order to carry out their function. We surveyed PM-targeting mechanisms by imaging the subcellular localization of 125 fluorescent protein-conjugated Ras, Rab, Arf, and Rho proteins. Out of 48 proteins that were PM-localized, 37 contained clusters of positively charged amino acids. To test whether these polybasic clusters bind negatively charged phosphatidylinositol 4,5-bisphosphate [PI(4,5)P 2 ] lipids, we developed a chemical phosphatase activation method to deplete PM PI(4,5)P 2 . Unexpectedly, proteins with polybasic clusters dissociated from the PM only when both PI(4,5)P 2 and phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P 3 ] were depleted, arguing that both lipid second messengers jointly regulate PM targeting.
S mall guanosine triphosphatases (GTPases) from the Ras, Rho, Arf, and Rab subfamilies often exert their role at the PM where they control diverse signaling, cytoskeletal, and transport processes (1) (2) (3) . KRas, CDC42, and other family members require a cluster of positively charged amino acids for PM localization and activity (2, 4) . In vitro studies indicate that the physiological PM binding partner of such polybasic clusters could be phosphatidylserine, which has one negative charge, or the less abundant lipid second messenger PI(4,5)P 2 , which has four negative charges (5-7). We took a genomic survey approach and investigated PM-targeting mechanisms by confocal imaging of 125 cyan fluorescent protein (CFP)-tagged constitutively active small GTPases (8) . Expression in NIH3T3 and HeLa cells showed that 48 small GTPases were fully or partially localized to the PM (Fig. 1A and fig. S1 ).
Thirty-seven of these PM-localized small GTPases had C-terminal polybasic clusters consisting of four or more Lys or Arg residues at positions 5 to 20 from the C terminus ( Fig. 1B  and fig. S1 ). Polybasic clusters were found in three forms: They were present together with N-terminal myristoylation consensus sequences (as in Arl4) (9) or with C-terminal prenylation consensus sequences (as in KRas) (5, 6, 10), or they lacked lipid modifications (as in Rit) (11) . We called these three combinations polybasicmyristoyl, polybasic-prenyl, and polybasicnonlipid PM-targeting motifs, respectively. A number of remaining PM-targeted small GTPases had a combined prenylation and palmitoylation consensus sequence that mediated PM targeting without requiring polybasic amino acids (as does that of HRas) (Fig. 1 , A and C) (5, 12) . Arf6 lacked a specific targeting motif and was only localized to the PM in its guanosine triphosphate (GTP)-bound form ( fig. S2) (13) . The sequence homology comparison of PM-localized small GTPases in Fig. 1C shows that closely homologous small GTPases can have different targeting motifs. We also confirmed, for the examples of Rit and KRas, that polybasic targeting motifs alone can be sufficient for PM targeting (Fig. 1D) .
To test whether polybasic clusters are anchored to the PM by binding to PI(4,5)P 2 (14), we hydrolyzed PM PI(4,5)P 2 by rapid targeting of Inp54p, a 5′ specific PI(4,5)P 2 phosphatase (15) , to the PM. This method is based on a PM-localized FK506-binding protein (FKBP12)-rapamycin-binding (FRB) construct and a cytosolic Inp54p enzyme conjugated with FKBP12 (CF-Inp) that can be translocated to the PM by chemical heterodimerization by using a rapamycin analog, iRap (16) .
In experiments where we monitored PI(4,5)P 2 using a yellow fluorescent protein (YFP)-conjugated pleckstrin homology (PH) domain from phospholipase Cd (PLCd) (17) , PM translocation of CF-Inp triggered a rapid and near complete dissociation of the YFP-PLCd-PH domain from the PM (Fig. 2A) . Despite this marked reduction in PI(4,5)P 2 concentration, only a small fraction of the polybasic-nonlipid tail fragment of Rit dissociated from the PM (Fig. 2B) (PDGF) led to a small increase in PM localization of the Rit tail and this small effect could be reversed by addition of an inhibitor of phosphoinositide 3-kinase (PI 3-kinase), LY294002 (LY29) ( Fig. 2C; control experiments in fig. S3 ). Strikingly, the combined reduction of both PI(4,5)P 2 and PI(3,4,5)P 3 concentration triggered a dissociation of most Rit tail protein from the PM (Fig. 2, D and E) . The effect of reducing either PI(4,5)P 2 or PI(3,4,5)P 3 concentration alone on Rit tail localization was relatively small (Fig. 2E) .
We also found that both PI(4,5)P 2 and PI(3,4,5)P 3 have to be lowered to significantly dissociate a tail fragment of Rin and a polybasic effector domain peptide from myristoylated alaninerich C kinase substrate (MARCKS) protein (MARCKS ED) from the PM (Fig. 2, D and E). This MARCKS ED peptide was included because it has been extensively used for in vitro biochemical studies of the interaction between polybasic amino acids and phosphatidylserine and PI(4,5)P 2 (7, 14, 18, 19) . HRas, which has a prenyl-palmitoyl PM-targeting motif without a polybasic cluster, did not dissociate from the PM after depletion of PI(4,5)P 2 and PI(3,4,5)P 3 ( Fig. 2E ). Control experiments with the same constructs in HeLa cells showed similar results ( fig.  S4 ), and an analysis of the dissociation kinetics showed that PM dissociation occurs within minutes after CF-Inp activation and LY29 addition ( fig. S5A ). We also verified that PM dissociation of polybasic proteins occurred when we combined PI(4,5)P 2 depletion with addition of wortmannin, an alternative PI 3-kinase inhibitor, or with expression of a dominant negative PI 3-kinase inhibitory construct (20) (figs. S6 and S7). Additional control experiments are shown in figs. S8 to S12, including in vitro lipid-blot assays that showed enhanced affinity of proteins with polybasic clusters for PI(3,4,5)P 3 over PI(4,5)P 2 . These control experiments strengthen the argument that PI(4,5)P 2 and the less abundant PI(3,4,5)P 3 both serve as PM anchors for proteins with polybasic clusters.
Insights into the electrostatic binding mechanism between positively charged polybasic clusters and negatively charged polyphosphoinositides came from a sequence comparison of nonprenylated PM-targeted small GTPases. Most of these proteins contain two or three subclusters of polybasic residues in the C-terminal tail. Each subcluster spans about four or five amino acids, and the mean distance between subclusters is nine amino acids (Fig. 3A) . Consistent with a need for multiple subclusters, the removal of a flanking subcluster in the Rit tail was sufficient to abolish PM targeting (Rit tail 199 to 219) (Fig.  3B ). This suggests that PM targeting results from additive binding energy of individual subclusters that each electrostatically interact with a PI(4,5)P 2 or PI(3,4,5)P 3 lipid. Selectivity for polyphosphoinositides over phosphatidylserine may occur because of opposing high relative-charge densities of polyphosphoinositides and polybasic subclusters (7) .
We then investigated differences between the targeting mechanisms of the three polybasicnonlipid, polybasic-myristoyl, and polybasicprenyl PM-targeting motifs. A distinct feature of the polybasic-nonlipid targeting motifs is their similarity to nuclear localization sequences. We found hydrophobic amino acids to be im- Ala in Rin) led to a complete loss of PM targeting and a strong nuclear localization (Fig. 3C) . A loss of PM targeting but with less nuclear targeting could also be observed for Leu 207 Ala and Phe 211 Ala Rit mutants (Fig. 3D ) and for hydrophobic amino acid mutants of the small GTPases GEM and RAD ( fig. S13 ). Thus, hydrophobic amino acids strengthen PM binding of polybasicnonlipid motifs and prevent the polybasic cluster from functioning as a nuclear localization sequence.
The polybasic-myristoyl PM-targeting motifs have the distinct feature of a separated N-terminal myristoylation consensus sequence and a Cterminal polybasic cluster. Mutant constructs showed that effective PM targeting of Arl7 required an N-terminal myristoyl motif (left panel, Fig. 4A ), as well as a flexible C-terminal polybasic tail (middle versus right panel, Fig. 4A ), which suggests that the two ends of the protein synergistically support PM targeting.
The polybasic-prenyl PM-targeting motif includes proteins such as KRas for which a 20-amino acid tail sequence is sufficient for farnesylation and PM targeting (Fig. 1D) , as well as Rab35 for which an intact GTPase domain is required for geranylgeranylation (21) and for PM targeting (second and third panels, Fig. 4B ). We further compared the roles of farnesylation and geranylgeranylation by creating a Rab35 mutant with a consensus CAAX farnesylation sequence in place of the geranylgeranylation sequence. This mutant showed PM localization indistinguishable from that of the geranylgeranylated Rab35 (fourth panel, Fig. 4B ). We also confirmed that the PM targeting of RAB35 requires a polybasic cluster (last panel, Fig. 4B ). This shows that the polybasic-geranylgeranyl motifs of Rab35 can be equally effective in PM targeting as the polybasic-farnesyl motif of KRas, which supports the notion that both types of prenylation motifs can be grouped into a single polybasicprenyl PM-targeting motif.
We then tested whether PI(4,5)P 2 and PI(3,4,5)P 3 also regulate polybasic-myristoyl and polybasic-prenyl targeting motifs. As for the polybasic-nonlipid targeting motif, depletion of PI(4,5)P 2 alone triggered only a minor reduction in PM localization of the Arl7 polybasicmyristoyl targeting motif and the KRas and Rab35 polybasic-prenyl motifs (Fig. 4C) . Depletion of both PI(4,5)P 2 and PI(3,4,5)P 3 triggered significant PM dissociation of all polybasicmyristoyl and polybasic-prenyl constructs tested (Fig. 4D) with a kinetics similar to that of Rit ( fig. S5 ), which suggests that PI(4,5)P 2 and PI(3,4,5)P 3 have the same role for PM localization for all three types of polybasic PM-targeting motifs. HRas was again included as a control protein without a polybasic cluster.
Our study shows that polybasic PM-targeting motifs are built from two parts, an unspecific membrane-targeting part that can be hydrophobic amino acids, myristoyl groups, or prenyl groups and a polybasic targeting part that provides PM specificity by binding of positively charged amino acid clusters to negatively charged PI(4,5)P 2 and PI(3,4,5)P 3 lipids in the PM. This gives PI(4,5)P 2 and PI(3,4,5)P 3 a ubiquitous role in regulating signaling, cytoskeletal, and transport proteins and argues that these lipid second messengers function as signaling hubs in cellular control systems. The inflammatory bowel diseases Crohn's disease and ulcerative colitis are common, chronic disorders that cause abdominal pain, diarrhea, and gastrointestinal bleeding. To identify genetic factors that might contribute to these disorders, we performed a genome-wide association study. We found a highly significant association between Crohn's disease and the IL23R gene on chromosome 1p31, which encodes a subunit of the receptor for the proinflammatory cytokine interleukin-23. An uncommon coding variant (rs11209026, c.1142G>A, p.Arg381Gln) confers strong protection against Crohn's disease, and additional noncoding IL23R variants are independently associated. Replication studies confirmed IL23R associations in independent cohorts of patients with Crohn's disease or ulcerative colitis. These results and previous studies on the proinflammatory role of IL-23 prioritize this signaling pathway as a therapeutic target in inflammatory bowel disease. C rohn's disease (CD) and ulcerative colitis (UC), the two common forms of idiopathic inflammatory bowel disease (IBD), are chronic, relapsing inflammatory disorders of the gastrointestinal tract. Each has a peak age of onset in the second to fourth decades of life and prevalences in European ancestry populations that average about 100 to 150 per 100,000 (1, 2) . Although the precise etiology of IBD remains to be elucidated, a widely accepted hypothesis is that ubiquitous, commensal intestinal bacteria trigger an inappropriate, overactive, and ongoing mucosal immune response that mediates intestinal tissue damage in genetically susceptible individuals (1). Genetic factors play an important role in IBD pathogenesis, as evidenced by the increased rates of IBD in Ashkenazi Jews, familial aggregation of IBD, and increased concordance for IBD in monozygotic compared to dizygotic twin pairs (3). Moreover, genetic analyses have linked IBD to specific genetic variants, especially CARD15 variants on chromosome 16q12 and the IBD5 haplotype (spanning the organic cation transporters, SLC22A4 and SLC22A5, and other genes) on chromosome 5q31 (3-7). CD and UC are thought to be related disorders that share some genetic susceptibility loci but differ at others.
The replicated associations between CD and variants in CARD15 and the IBD5 haplotype do not fully explain the genetic risk for CD, so we performed a genome-wide association study testing 308,332 autosomal single nucleotide polymorphisms (SNPs) on the Illumina HumanHap300 Genotyping BeadChip (8) . Our study population consisted of 567 nonJewish, European ancestry patients with ileal CD and 571 non-Jewish controls. We initially focused on ileal CD, the most common location of CD, to minimize pathogenic heterogeneity. After exclusion of study subjects with genotype completion rates less than 94%, we included 547 cases and 548 controls in subsequent analyses (8) . Single-marker allelic tests were performed using c 2 statistics for all autosomal markers. Three SNPs had nearly two orders of magnitude greater significance compared to the next most significant markers, and they are the only markers that remain significant at the 0.05 level after Bonferroni correction. Two of the three markers, rs2066843 (P = 2.86 × 10 , corrected P = 1.56 × 10 −3 ), is a nonsynonymous SNP (c.1142G>A, p.Arg381Gln) in the IL23R gene (GenBank accession: NM_144701, GeneID: 149233) on chromosome 1p31. This gene encodes a subunit of the receptor for the proinflammatory cytokine, interleukin-23 (IL-23), and is therefore an intriguing functional candidate. In addition to Arg381Gln, nine other markers in IL23R and in the intergenic region between IL23R and the adjacent IL-12 receptor, beta-2 gene (IL12RB2), had association Pvalues < 0.0001 in the non-Jewish, ileal CD case-control cohort (Table 1 and table S1a) .
We next tested for association of IL23R markers in an independent ileal CD case-control cohort, consisting of 401 patients and 433 controls, all of Jewish ancestry (8) . Significant associations were observed for several of the same markers that were associated in the non-Jewish cohort (Table 1 and table S1b ). In a combined analysis of the data from the two ileal CD casecontrol cohorts (8) , nine markers had highly significant association P-values ranging from 1.60 × 10 −9 to 3.36 × 10 −13 (Table 1 and table S1b ). We then extended the replication study by performing family-based association testing of 27 IL23R region markers in an independent cohort of 883 nuclear families in which both par-
